Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 60, Issue 13, Pages 5377-5391Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b01915
Keywords
-
Categories
Funding
- Science & Technology Development Fund in Egypt (STDF) through the GE-SEED [17391]
- Deutsche Forschungsgemeinschaft (DFG) [EN381/2-3]
Ask authors/readers for more resources
In cancer cells, kinases of the Clk family control the supply of full-length, functional mRNAs coding for a variety of proteins essential to cell growth and survival. Thus, inhibition of Clks might become a novel anticancer strategy, leading to a selective depletion of cancer-relevant proteins after turnover. On the basis of a Weinreb amide hit compound, we designed and synthesized a diverse set of methoxybenzothiophene-2-carboxamides, of which the N-benzylated derivative showed enhanced Clk1 inhibitory activity. Introduction of a m-fluorine in the benzyl moiety eventually led to the discovery of compound 21b, a potent inhibitor of Clk1 and -4 (IC50 = 7 and 2.3 nM, respectively), exhibiting an unprecedented selectivity over Dyrk1A. 21b triggered the depletion of EGFR, HDAC1, and p70S6 kinase from the cancer cells, with potencies in line with the measured GI(50) values. In contrast, the cellular effects of congener 21a, which inhibited Clk1 only weakly, were substantially lower.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available